🕵️ Sarepta Therapeutics, Inc. ($SRPT)
SEC insider & ownership activity, last 12 months · CIK 873303 · every row links its SEC filing
Over the last 12 months insiders sold $417K with no open-market buying against it. Ian M Estepan sold $294K in discretionary trades (Dec). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 2 sellers, $417K (2 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Ian M Estepan | 0 | – | 1 | $294K | Dec 16, 2025 |
| Mayo Stephen | 0 | – | 1 | $123K | Mar 12, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Blackrock, Inc. | 12.6% | 13G | Jan 21, 2026 | filing ↗ | |
| AQR Capital Management, LLC | 7.7% | 13G | Feb 13, 2026 | filing ↗ | |
| AQR Capital Management Holdings, LLC | 7.7% | 13G | Feb 13, 2026 | filing ↗ | |
| Vanguard Portfolio Management | 6.4% | 13G | Apr 29, 2026 | filing ↗ | |
| State Street Corporation | 5.4% | 13G | Nov 10, 2025 | filing ↗ | |
| Vanguard Capital Management | 5.1% | 13G | Apr 30, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Stephen Mayo | $123K | Mar 12, 2026 | filing ↗ |
| Ian M Estepan | $294K | Dec 16, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Jul 23, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jul 23, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 23, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 4, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 4, 2026 | filing ↗ |
| Earnings (2.02) | May 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 6, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 25, 2026 | filing ↗ |
| Earnings (2.02) | Feb 25, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 25, 2026 | filing ↗ |
| Earnings (2.02) | Jan 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 12, 2026 | filing ↗ |
| Material agreement (1.01) | Dec 18, 2025 | filing ↗ |
| New financial obligation (2.03) | Dec 18, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 18, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Dec 10, 2025 | filing ↗ |
| Other events (8.01) | Dec 10, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 10, 2025 | filing ↗ |
| Officer/director changes (5.02) | Dec 7, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 7, 2025 | filing ↗ |
| Earnings (2.02) | Nov 3, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 3, 2025 | filing ↗ |
| Material agreement (1.01) | Aug 28, 2025 | filing ↗ |
| New financial obligation (2.03) | Aug 28, 2025 | filing ↗ |
| Other events (8.01) | Aug 28, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 28, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Aug 18, 2025 | filing ↗ |
| Officer/director changes (5.02) | Aug 12, 2025 | filing ↗ |